Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Does food addiction exist? A phenomenological discussion based on the psychiatric classification of substance-related disorders and addiction.

Albayrak O, Wölfle SM, Hebebrand J.

Obes Facts. 2012;5(2):165-79. doi: 10.1159/000338310. Epub 2012 Apr 19.

2.

Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale.

Brünen S, Vincent PD, Baumann P, Hiemke C, Havemann-Reinecke U.

Ther Drug Monit. 2011 Oct;33(5):561-72. doi: 10.1097/FTD.0b013e31822fbf7c. Review.

PMID:
21912330
3.

Topiramate in the treatment of substance-related disorders: a critical review of the literature.

Shinn AK, Greenfield SF.

J Clin Psychiatry. 2010 May;71(5):634-48. doi: 10.4088/JCP.08r04062gry. Epub 2010 Mar 9. Review.

4.

Racial/ethnic variations in substance-related disorders among adolescents in the United States.

Wu LT, Woody GE, Yang C, Pan JJ, Blazer DG.

Arch Gen Psychiatry. 2011 Nov;68(11):1176-85. doi: 10.1001/archgenpsychiatry.2011.120.

5.

Should addictive disorders include non-substance-related conditions?

Potenza MN.

Addiction. 2006 Sep;101 Suppl 1:142-51. Review.

PMID:
16930171
6.

Gender similarities and differences: the prevalence and course of alcohol- and other substance-related disorders.

Zilberman M, Tavares H, el-Guebaly N.

J Addict Dis. 2003;22(4):61-74. Review.

PMID:
14723478
7.

Assessment and treatment of alcoholism and substance-related disorders in the elderly.

Menninger JA.

Bull Menninger Clin. 2002 Spring;66(2):166-83.

PMID:
12141383
8.

Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.

Ma Q, Zingman BS, Luque AE, Fischl MA, Gripshover BM, Venuto CS, DiFrancesco R, Forrest A, Morse GD.

Ther Drug Monit. 2011 Jun;33(3):309-14. doi: 10.1097/FTD.0b013e31821d3adb.

9.

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X.

Biol Psychiatry. 2007 Apr 1;61(7):911-22. Epub 2007 Jan 9.

PMID:
17217930
10.

Substance-related disorders among juvenile offenders: what role do psychopathic traits play?

Kimonis ER, Tatar JR 2nd, Cauffman E.

Psychol Addict Behav. 2012 Jun;26(2):212-25. doi: 10.1037/a0028047. Epub 2012 May 7.

11.

The role of child sexual abuse in the etiology of substance-related disorders.

Maniglio R.

J Addict Dis. 2011 Jul-Sep;30(3):216-28. doi: 10.1080/10550887.2011.581987. Review.

PMID:
21745044
12.

Mnemonics for DSM-IV substance-related disorders.

Pinkofsky HB, Reeves RR.

Gen Hosp Psychiatry. 1998 Nov;20(6):368-70.

PMID:
9854649
14.

Functional associations among trauma, PTSD, and substance-related disorders.

Stewart SH, Pihl RO, Conrod PJ, Dongier M.

Addict Behav. 1998 Nov-Dec;23(6):797-812. Review.

PMID:
9801717
15.

Prevalence studies of substance-related disorders: a systematic review of the literature.

Somers JM, Goldner EM, Waraich P, Hsu L.

Can J Psychiatry. 2004 Jun;49(6):373-84. Review.

PMID:
15283532
16.
17.

Substance-related disorders and somatic symptoms: how should clinicians understand the associations?

Yoshimasu K.

Curr Drug Abuse Rev. 2012 Dec;5(4):291-303. Review.

PMID:
23244342
18.

Affective, anxiety, and substance-related disorders in patients undergoing herniated disc surgery.

Zieger M, Luppa M, Matschinger H, Meisel HJ, Günther L, Meixensberger J, Toussaint R, Angermeyer MC, König HH, Riedel-Heller SG.

Soc Psychiatry Psychiatr Epidemiol. 2011 Nov;46(11):1181-90. doi: 10.1007/s00127-010-0283-2. Epub 2010 Sep 9.

PMID:
20827459
19.

Attrition factors in clinical trials of comorbid bipolar and substance-related disorders.

Nomamiukor N, Brown ES.

J Affect Disord. 2009 Jan;112(1-3):284-8. doi: 10.1016/j.jad.2008.04.016. Epub 2008 May 29.

PMID:
18511129
20.

Diagnosing co-occurring substance-related disorders: agreement between SCID, Hispanic clinicians, and Non-Hispanic clinicians.

Torres LR, Zayas LH, Cabassa LJ, Pérez MC.

J Clin Psychiatry. 2007 Nov;68(11):1655-62.

PMID:
18052558

Supplemental Content

Support Center